Myriad Genetics Files 2024 10-K Report
Ticker: MYGN · Form: 10-K · Filed: Feb 28, 2025 · CIK: 899923
| Field | Detail |
|---|---|
| Company | Myriad Genetics Inc (MYGN) |
| Form Type | 10-K |
| Filed Date | Feb 28, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, financials, healthcare
Related Tickers: MYGN
TL;DR
MYGN 2024 10-K is in. Full financials for 2024, 2023, 2022 available. Check it out.
AI Summary
Myriad Genetics Inc. filed its 2024 10-K report on February 28, 2025, detailing its financial performance for the fiscal year ending December 31, 2024. The company, based in Salt Lake City, UT, operates in the in vitro and in vivo diagnostic substances sector. The filing includes financial data for the fiscal years 2024, 2023, and 2022, covering aspects like common stock, additional paid-in capital, accumulated other comprehensive income, and retained earnings.
Why It Matters
This 10-K filing provides investors and stakeholders with a comprehensive overview of Myriad Genetics' financial health and operational performance for the past fiscal year, crucial for investment decisions.
Risk Assessment
Risk Level: medium — The company operates in the highly regulated and competitive healthcare sector, which presents inherent risks.
Key Numbers
- 2024 — Fiscal Year (Reporting period for the 10-K)
- 2023 — Fiscal Year (Comparative financial data)
- 2022 — Fiscal Year (Comparative financial data)
Key Players & Entities
- MYRIAD GENETICS INC (company) — Filer
- SALT LAKE CITY, UT (location) — Business Address
- 2024-12-31 (date) — Fiscal Year End
- 2025-02-28 (date) — Filing Date
FAQ
What is the primary business of Myriad Genetics Inc.?
Myriad Genetics Inc. operates in the 'IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES' sector, as indicated by its SIC code [2835].
When was the 10-K filing submitted?
The 10-K filing was submitted on February 28, 2025.
What fiscal year does this 10-K report cover?
This 10-K report covers the fiscal year ending December 31, 2024.
Where is Myriad Genetics Inc. headquartered?
Myriad Genetics Inc. is located at 322 NORTH 2200 WEST, SALT LAKE CITY, UT 84116.
What financial components are detailed for the fiscal years 2021-2024?
The filing details components such as Common Stock, Additional Paid-In Capital, Accumulated Other Comprehensive Income, and Retained Earnings for the fiscal years ending 2021, 2022, 2023, and 2024.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 28, 2025 regarding MYRIAD GENETICS INC (MYGN).